George Kenneth Lewis
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$17.5MFederal grants as PI16 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
16 awards · $17.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 17, 2026 | NIH | SBIR Phase II Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis | $2.2M | ZETROZ SYSTEMS LLC |
| Aug 5, 2025 | NIH | SBIR Phase II Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis | $2.4M | ZETROZ SYSTEMS LLC |
| Feb 21, 2025 | NIH | SBIR Phase II Clinical Optimization of Ultrasonic Drug Delivery Technologies for US Veteran Populations that Experience Health Disparities with Arthritis and Chronic Pain | $1.5M | ZETROZ SYSTEMS LLC |
| Sep 18, 2024 | NIH | SBIR Phase II Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis | $2.2M | ZETROZ SYSTEMS LLC |
| Mar 6, 2024 | NIH | SBIR Phase II Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain | $1.6M | ZETROZ SYSTEMS LLC |
| Aug 10, 2023 | NIH | SBIR Phase II Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain | $1.5M | ZETROZ SYSTEMS LLC |
| Jun 3, 2022 | NIH | SBIR Phase II Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis | $1.4M | ZETROZ SYSTEMS LLC |
| Jun 9, 2021 | NIH | SBIR Phase I Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain | $234K | ZETROZ SYSTEMS LLC |
| May 27, 2021 | NIH | SBIR Phase II Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis | $1.4M | ZETROZ SYSTEMS LLC |
| Sep 15, 2020 | NIH | SBIR Phase II Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis | $1.4M | ZETROZ SYSTEMS LLC |
| Sep 14, 2020 | NIH | SBIR Phase I Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain | $218K | ZETROZ SYSTEMS LLC |
| Aug 5, 2019 | NIH | SBIR Phase I Daily and localized NSAID sonophoresis for symptomatic treatment of knee osteoarthritis | $224K | ZETROZ SYSTEMS LLC |
| Sep 18, 2018 | NIH | SBIR Phase I Daily and localized NSAID sonophoresis for symptomatic treatment of knee osteoarthritis | $224K | ZETROZ SYSTEMS LLC |
| Jun 8, 2017 | NIH | SBIR Phase II Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations | $400K | ZETROZ SYSTEMS LLC |
| Jun 23, 2016 | NIH | SBIR Phase II Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations | $400K | ZETROZ SYSTEMS LLC |
| Apr 21, 2016 | NIH | SBIR Phase II Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations | $269K | ZETROZ SYSTEMS LLC |
Peer ranks
Federal funding#14
Awards as PI#48
Patents#505
Companies
- ZETROZ SYSTEMS LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.